Pulmonary Disorders and COVID-19: Difference between revisions

Jump to navigation Jump to search
Tag: New redirect
 
(30 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[COVID-19 Pulmonary Complications]]
To go to the COVID-19 project topics list, click '''[[COVID-19 Project Topics|here]]'''.
 
{{CMG}} {{AE}} {{S.M.}}
==Overview==
[[Covid19|Covid-19]] [[infection]] is [[Association (statistics)|associated]] with [[pulmonary]] [[complications]] such as [[acute respiratory distress syndrome]], [[pneumonia]], [[pulmonary embolism]], [[hypoxemia]], [[superinfection]], [[respiratory failure]], and increased [[mortality]] in [[patients]] with an [[Underlying representation|underlying]] [[pulmonary disease]] such as [[chronic obstructive pulmonary disease]] ([[Chronic obstructive pulmonary disease|COPD]]).
 
==Complications==
 
===Acute respiratory distress syndrome===
*
 
===Pneumonia===
 
===Pulmonary embolism===
 
===Hypoxemia===
 
===Superinfection===
 
===Respiratory failure===
 
===Increased mortality in COPD patients===
*According to a [[Study design|study]] [[Conduct|conducted]] in China, having an [[Underlying representation|underlying]] [[comorbidity]] such as [[chronic obstructive pulmonary disease]] ([[Chronic obstructive pulmonary disease|COPD]]) conferred a [[mortality]] [[hazard ratio]] of 2.681, even after adjusting for [[smoking]] status.
 
==References==
<references />

Latest revision as of 01:29, 24 June 2020